These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17899308

  • 1. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
    Leung KC, McMillan AS, Wong MC, Leung WK, Mok MY, Lau CS.
    Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P.
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [Abstract] [Full Text] [Related]

  • 3. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
    Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY.
    Arch Intern Med; 2002 Jun 10; 162(11):1293-300. PubMed ID: 12038948
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K.
    Am J Ophthalmol; 2004 Jul 10; 138(1):6-17. PubMed ID: 15234277
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, Yamane T, Murata M, Tsumiyama K, Hashiramoto A, Shiozawa S.
    Mod Rheumatol; 2009 Jul 10; 19(4):416-9. PubMed ID: 19452244
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
    Noaiseh G, Baker JF, Vivino FB.
    Clin Exp Rheumatol; 2014 Jul 10; 32(4):575-7. PubMed ID: 25065774
    [Abstract] [Full Text] [Related]

  • 10. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
    Suzuki K, Matsumoto M, Nakashima M, Takada K, Nakanishi T, Okada M, Ohsuzu F.
    Pharmacology; 2005 May 10; 74(2):100-5. PubMed ID: 15722648
    [Abstract] [Full Text] [Related]

  • 11. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
    Chambers MS, Posner M, Jones CU, Biel MA, Hodge KM, Vitti R, Armstrong I, Yen C, Weber RS.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1102-9. PubMed ID: 17379432
    [Abstract] [Full Text] [Related]

  • 12. Cevimeline.
    Weber J, Keating GM.
    Drugs; 2008 Jul 15; 68(12):1691-8. PubMed ID: 18681491
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
    Takagi Y, Sumi M, Nakamura H, Sato S, Kawakami A, Nakamura T.
    Rheumatology (Oxford); 2016 Feb 15; 55(2):237-45. PubMed ID: 26338664
    [Abstract] [Full Text] [Related]

  • 15. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I, Taylor SE.
    Tex Dent J; 2001 Apr 15; 118(3):262-6. PubMed ID: 11404944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y, Kimura Y, Nakamura T.
    Ann Rheum Dis; 2004 Jun 15; 63(6):749. PubMed ID: 15140789
    [No Abstract] [Full Text] [Related]

  • 18. Salivary hypofunction and xerostomia: diagnosis and treatment.
    Atkinson JC, Grisius M, Massey W.
    Dent Clin North Am; 2005 Apr 15; 49(2):309-26. PubMed ID: 15755407
    [Abstract] [Full Text] [Related]

  • 19. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
    Chambers MS, Jones CU, Biel MA, Weber RS, Hodge KM, Chen Y, Holland JM, Ship JA, Vitti R, Armstrong I, Garden AS, Haddad R.
    Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1369-76. PubMed ID: 17855005
    [Abstract] [Full Text] [Related]

  • 20. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI, Konttinen Y, Fisher A.
    Clin Immunol; 2001 Dec 01; 101(3):249-63. PubMed ID: 11726216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.